Talkspace, Inc. (“Talkspace”) (Nasdaq: TALK), a leading virtual
behavioral healthcare company, today reported its financial results
for the third quarter ended September 30, 2021.
Jennifer Fulk, Chief Financial Officer of
Talkspace, commented: “While Net Revenue grew 23% year-over-year,
driven by continued momentum in the B2B business, the overall
financial results for the third quarter were disappointing. Q3 Net
Revenue came in below management expectations due to a lower number
of B2C customers and a one-time non-cash reserve adjustment for
credit losses on receivables related to prior periods. The $223
million of available liquidity as of September 30 will allow
Talkspace to invest in important operational enhancements and new
initiatives that will continue to drive long‐term growth.”
Third Quarter 2021 Financial
Highlights
- Net Revenue of $26.4 million, a 23% increase over the
prior-year period
- Gross Profit of $14.2 million; Gross Margin of 54% compared to
70% in the prior-year period
- Adjusted EBITDA loss of ($20.8) million, compared to ($2.0)
million in the prior-year period
- Net income of $1.5 million, compared to a net loss of ($2.7)
million in the prior-year period
Key Operating Metrics
- Total active members grew 21% year-over-year to approximately
60,300 as of September 30, 2021
- B2B eligible lives grew 92% year-over-year to over 75 million
as of September 30, 2021
- 71,300 completed B2B sessions, a 96% increase versus the
prior‐year period
Revenue
- Net Revenue for the third quarter was $26.4 million, a 23%
year‐over‐year increase. This metric came in below expectations due
to a lower number of acquired customers in the direct‐to‐consumer
business and an adjustment to reserves, which was only partially
offset by growth in B2B Gross Revenue.
- In the third quarter we increased the allowance for credit
losses on receivables by $3.4 million, of which $2.8 million
related to prior quarters. Excluding the impact of this one‐time
non‐cash adjustment, consolidated Revenue would have been $29.2
million, up 37% year‐over‐year.
- Direct‐to‐consumer Revenue was $18.6 million, a 10%
year‐over‐year increase in the third quarter. The slowdown in the
B2C business resulted in part from delays in launching new products
and features, as well as a decline in conversion rates.
- B2B Revenue was $7.7 million, a 69% increase year‐over‐year,
with the continued strong performance of recurring revenue coming
from PEPM fees, which approximately tripled year‐over‐year.
Gross Margin
- Gross profit was $14.2 million in the third quarter, compared
to $15.1 million in the prior-year quarter. Gross margin was 54%
compared to 70% a year ago. This decline was due to the increase in
the reserve for credit losses on receivables, revenue mix shift
towards B2B, and the continued investment in W2 therapist
network.
- Excluding the reserve adjustment related to prior quarters,
gross profit and margin for the quarter would have been $17.0
million and 58%, respectively.
Net Income
- Net income was $1.5 million compared to a net loss of $2.7
million in the prior‐year period. This reflects a $26.9 million
non‐cash gain resulting from the revaluation of the warrants’
liabilities, driven by lower share price.
The following table summarizes the Company’s
performance during the third quarter of 2021, compared to the same
period in 2020:
|
Three Months Ended September 30, |
|
Period-Over-Period |
(Values in
thousands, except B2B eligible lives and percentages) |
2021 |
|
2020 |
|
Change |
Number of B2B eligible lives at period end (in millions) |
|
75.3 |
|
|
39.2 |
|
92% |
Total number
of active members at period end |
|
60.3 |
|
|
49.9 |
|
21% |
Total number
of completed B2B sessions |
|
71.3 |
|
|
36.4 |
|
96% |
|
|
Net
revenue |
$ |
26,359 |
|
$ |
21,505 |
|
23% |
Gross
profit |
|
14,172 |
|
|
15,091 |
|
(6%) |
Gross margin
% |
|
53.8% |
|
|
70.2% |
|
(1,600)
basis points |
Operating
expenses |
|
39,399 |
|
|
17,495 |
|
125% |
Net income
(loss) |
|
1,505 |
|
|
(2,692) |
|
* |
Adjusted
EBITDA (1) |
$ |
(20,849) |
|
$ |
(2,049) |
|
* |
* Not meaningful (1) Adjusted EBITDA is a
non-GAAP financial measure. Refer to “Reconciliation of Non-GAAP
Results to GAAP Results” table below.
Conference Call and Webcast
Details
The Company will host a conference call at 5:00
p.m. E.T. on Monday, November 15th, to discuss these results and
management’s outlook for future financial and operational
performance. A live audio webcast will be available online at
https://investors.talkspace.com/. The conference call can also be
accessed by dialing (800) 708-4540 for U.S. participants, or (847)
619-6397 for international participants, and referencing
participant code 50240837. A replay of the call will be available
via webcast for on-demand listening shortly after the completion of
the call, at the same web link, and will remain available for
approximately 90 days.
About Talkspace
Talkspace is a leading virtual behavioral
healthcare company enabled by a purpose-built technology platform.
As a digital healthcare company, all care is delivered through an
easy-to-use and fully encrypted web and mobile platform, consistent
with HIPAA and other state regulatory requirements.
Today, the need for care feels more urgent than
ever. When seeking treatment, whether it's psychiatry or
adolescent, individual or couples therapy, Talkspace offers
treatment options for almost every need. With Talkspace, members
can send their dedicated therapists text, video, and voice messages
anytime, from anywhere, and engage in live video sessions. As of
September 2021, over 2 million people have used Talkspace, and over
75 million lives were covered for Talkspace through insurance and
employee assistance programs or other network behavioral health
paid benefit programs.
For more information about Talkspace commercial
relationships, visit https://business.talkspace.com/. To learn more
about online therapy, please visit:
https://www.talkspace.com/online-therapy/. To learn more about
Talkspace Psychiatry, please visit
https://www.talkspace.com/psychiatry.
Forward Looking Statements
This press release contains certain
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, as amended. All
statements contained in this press release that do not relate to
matters of historical fact should be considered forward-looking,
including statements regarding our financial condition, anticipated
financial performance, business strategy and plans, market
opportunity and expansion and objectives of our management for
future operations. These forward-looking statements generally are
identified by the words “anticipate,” “believe,” “contemplate,”
“continue,” “could,” “estimate,” “expect,” “forecast”, “future”,
“intend,” “may,” “might”, “opportunity”, “plan,” “possible”,
“potential,” “predict,” “project,” “should,” “strategy”, “strive”,
“target,” “will,” or “would”, the negative of these words or other
similar terms or expressions. The absence of these words does not
mean that a statement is not forward-looking. Forward-looking
statements are predictions, projections and other statements about
future events that are based on current expectations and
assumptions and, as a result, are subject to risks and
uncertainties. Many important factors could cause actual future
events to differ materially from the forward-looking statements in
this press release, including but not limited to: our history of
losses; the rapid evolution of our business and the markets in
which we operate; our ability to continue growing at the rates we
have historically grown, or at all; the development of the virtual
behavioral health market; COVID-19 and its impact on business and
economic conditions; competition in our industry; and our
relationships with affiliated professional entities to provide
physician and other professional services. The foregoing list of
factors is not exhaustive. You should carefully consider the
foregoing factors and the other risks and uncertainties described
in under the caption “Risk Factors” in our prospectus dated July
12, 2021 (File No. 333-257686), as filed with the Securities and
Exchange Commission (“SEC”) pursuant to Rule 424(b)(4) under the
Securities Act of 1933, as amended, our Quarterly Report on Form
10-Q for the quarterly period ended September 30, 2021 to be
filed with the SEC, and our other documents filed from time to time
with the SEC. These filings identify and address other important
risks and uncertainties that could cause actual events and results
to differ materially from those contained in the forward-looking
statements. Forward-looking statements speak only as of the date
they are made. Readers are cautioned not to put undue reliance on
forward-looking statements, and we assumes no obligation and do not
intend to update or revise these forward-looking statements,
whether as a result of new information, future events, or
otherwise. We do not give any assurance that we will achieve our
expectations.
Contacts
For Investors: Westwicke, an ICR Company Bob East
/ Asher Dewhurst / Jordan Kohnstam 443-213-0500
TalkspaceIR@westwicke.com
Talkspace, Inc.
Condensed Consolidated Statements of Income (Loss)
(Unaudited)
|
|
Three months ended September
30, |
|
|
Variance |
|
|
Nine months ended September
30, |
|
|
Variance |
|
|
|
2021 |
|
|
2020 |
|
|
$ |
|
|
% |
|
|
2021 |
|
|
2020 |
|
|
$ |
|
|
% |
|
(in thousands, except
percentages and per share data) |
|
|
|
|
Consumer revenue |
|
$ |
18,631 |
|
|
$ |
16,923 |
|
|
$ |
1,708 |
|
|
|
10.1 |
|
|
$ |
58,286 |
|
|
$ |
42,208 |
|
|
$ |
16,078 |
|
|
|
38.1 |
|
Commercial
revenue |
|
|
7,728 |
|
|
|
4,582 |
|
|
|
3,146 |
|
|
|
68.7 |
|
|
|
26,213 |
|
|
|
8,294 |
|
|
|
17,919 |
|
|
|
216.0 |
|
Total
revenue |
|
|
26,359 |
|
|
|
21,505 |
|
|
|
4,854 |
|
|
|
22.6 |
|
|
|
84,499 |
|
|
|
50,502 |
|
|
|
33,997 |
|
|
|
67.3 |
|
Cost of
revenues |
|
|
12,187 |
|
|
|
6,414 |
|
|
|
5,773 |
|
|
|
90.0 |
|
|
|
33,698 |
|
|
|
17,394 |
|
|
|
16,304 |
|
|
|
93.7 |
|
Gross
profit |
|
|
14,172 |
|
|
|
15,091 |
|
|
|
(919 |
) |
|
|
(6.1 |
) |
|
|
50,801 |
|
|
|
33,108 |
|
|
|
17,693 |
|
|
|
53.4 |
|
Operating
expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development, net |
|
|
4,278 |
|
|
|
2,199 |
|
|
|
2,079 |
|
|
|
94.5 |
|
|
|
12,023 |
|
|
|
7,327 |
|
|
|
4,696 |
|
|
|
64.1 |
|
Clinical operations |
|
|
1,896 |
|
|
|
899 |
|
|
|
997 |
|
|
|
110.9 |
|
|
|
5,886 |
|
|
|
2,535 |
|
|
|
3,351 |
|
|
|
132.2 |
|
Sales and marketing |
|
|
26,431 |
|
|
|
12,660 |
|
|
|
13,771 |
|
|
|
108.8 |
|
|
|
75,125 |
|
|
|
30,020 |
|
|
|
45,105 |
|
|
|
150.2 |
|
General and administrative |
|
|
6,794 |
|
|
|
1,737 |
|
|
|
5,057 |
|
|
|
291.1 |
|
|
|
23,112 |
|
|
|
4,198 |
|
|
|
18,914 |
|
|
|
450.5 |
|
Total
operating expenses |
|
|
39,399 |
|
|
|
17,495 |
|
|
|
21,904 |
|
|
|
125.2 |
|
|
|
116,146 |
|
|
|
44,080 |
|
|
|
72,066 |
|
|
|
163.5 |
|
Operating
loss |
|
|
(25,227 |
) |
|
|
(2,404 |
) |
|
|
(22,823 |
) |
|
|
(949.4 |
) |
|
|
(65,345 |
) |
|
|
(10,972 |
) |
|
|
(54,373 |
) |
|
|
(495.6 |
) |
Financial
income (expense), net |
|
|
26,743 |
|
|
|
(285 |
) |
|
|
27,028 |
|
|
* |
|
|
|
23,700 |
|
|
|
(254 |
) |
|
|
23,954 |
|
|
* |
|
Income
(loss) before taxes on income |
|
|
1,516 |
|
|
|
(2,689 |
) |
|
|
4,205 |
|
|
|
156.4 |
|
|
|
(41,645 |
) |
|
|
(11,226 |
) |
|
|
(30,419 |
) |
|
|
(271.0 |
) |
Taxes on
income |
|
|
11 |
|
|
|
3 |
|
|
|
8 |
|
|
|
266.7 |
|
|
|
29 |
|
|
|
12 |
|
|
|
17 |
|
|
|
141.7 |
|
Net income
(loss) |
|
|
1,505 |
|
|
|
(2,692 |
) |
|
|
4,197 |
|
|
|
155.9 |
|
|
|
(41,674 |
) |
|
|
(11,238 |
) |
|
|
(30,436 |
) |
|
|
(270.8 |
) |
Net income (loss) per
share (1): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.01 |
|
|
$ |
(0.20 |
) |
|
$ |
0.21 |
|
|
|
104.9 |
|
|
$ |
(0.64 |
) |
|
$ |
(0.84 |
) |
|
$ |
0.20 |
|
|
|
23.4 |
|
Diluted |
|
$ |
0.01 |
|
|
$ |
(0.20 |
) |
|
$ |
0.21 |
|
|
|
104.5 |
|
|
$ |
(0.64 |
) |
|
$ |
(0.84 |
) |
|
$ |
0.20 |
|
|
|
23.4 |
|
Weighted average
number of common shares (1): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
152,268 |
|
|
|
13,375 |
|
|
|
|
|
|
|
|
|
64,638 |
|
|
|
13,349 |
|
|
|
|
|
|
|
Diluted |
|
|
165,179 |
|
|
|
13,375 |
|
|
|
|
|
|
|
|
|
64,638 |
|
|
|
13,349 |
|
|
|
|
|
|
|
* = not meaningful (1) Prior period results have
been adjusted to reflect the exchange of Old Talkspace’s common
stock for Talkspace’s common stock at an exchange ratio of
approximately 1.134140 in June 2021 as a result of the
Business Combination.
Talkspace, Inc.
Condensed Consolidated Balance Sheets
|
|
September 30,2021 |
|
|
December 31,2020 |
|
(in
thousands) |
|
(Unaudited) |
|
|
|
|
ASSETS |
|
|
|
|
|
|
CURRENT
ASSETS: |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
222,865 |
|
|
$ |
13,248 |
|
Accounts receivable, net |
|
|
5,318 |
|
|
|
5,914 |
|
Other current assets |
|
|
10,023 |
|
|
|
1,515 |
|
Total current assets |
|
|
238,206 |
|
|
|
20,677 |
|
Property and equipment, net |
|
|
658 |
|
|
|
175 |
|
Deferred issuance costs |
|
|
- |
|
|
|
692 |
|
Intangible assets, net |
|
|
3,876 |
|
|
|
5,195 |
|
Goodwill |
|
|
6,134 |
|
|
|
6,134 |
|
Other long-term assets |
|
|
82 |
|
|
|
- |
|
Total assets |
|
$ |
248,956 |
|
|
$ |
32,873 |
|
LIABILITIES,
CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT |
|
|
|
|
|
|
CURRENT
LIABILITIES: |
|
|
|
|
|
|
Accounts payable |
|
$ |
14,039 |
|
|
$ |
7,901 |
|
Deferred revenues |
|
|
8,302 |
|
|
|
5,172 |
|
Accrued expenses and other current liabilities |
|
|
7,634 |
|
|
|
7,416 |
|
Total current liabilities |
|
|
29,975 |
|
|
|
20,489 |
|
Warrant
liabilities |
|
|
12,012 |
|
|
|
- |
|
Other
long-term liabilities |
|
|
86 |
|
|
|
- |
|
Total
liabilities |
|
|
42,073 |
|
|
|
20,489 |
|
Convertible
preferred stock |
|
|
- |
|
|
|
111,282 |
|
STOCKHOLDERS’ EQUITY (DEFICIT): |
|
|
|
|
|
|
Common stock (1) |
|
|
15 |
|
|
|
1 |
|
Additional paid-in capital (1) |
|
|
357,330 |
|
|
|
9,889 |
|
Accumulated deficit |
|
|
(150,462 |
) |
|
|
(108,788 |
) |
Total stockholders’ equity (deficit) |
|
|
206,883 |
|
|
|
(98,898 |
) |
Total liabilities, convertible preferred stock and
stockholders’ equity (deficit) |
|
$ |
248,956 |
|
|
$ |
32,873 |
|
(1) Prior period results have been adjusted to
reflect the exchange of Old Talkspace’s common stock for
Talkspace’s common stock at an exchange ratio of
approximately 1.134140 in June 2021 as a result of the
Business Combination.
Talkspace, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
|
|
Nine months ended September
30, |
|
(in
thousands) |
|
2021 |
|
|
2020 |
|
Cash flows
from operating activities: |
|
|
|
|
|
|
Net loss |
|
$ |
(41,674 |
) |
|
$ |
(11,238 |
) |
Adjustments
to reconcile net loss to net cash used in operating
activities: |
|
|
|
|
|
|
Depreciation and amortization |
|
|
1,458 |
|
|
|
55 |
|
Amortization of debt issuance cost |
|
|
175 |
|
|
|
— |
|
Stock-based compensation |
|
|
20,584 |
|
|
|
1,069 |
|
Change in fair value of warrants |
|
|
(23,842 |
) |
|
|
— |
|
Increase in accounts receivable |
|
|
596 |
|
|
|
(3,045 |
) |
Increase in other current assets |
|
|
(8,515 |
) |
|
|
(1,108 |
) |
Increase in accounts payable |
|
|
7,113 |
|
|
|
2,021 |
|
Increase in deferred revenues |
|
|
3,130 |
|
|
|
3,390 |
|
(Decrease) increase in accrued expenses and other current
liabilities |
|
|
(134 |
) |
|
|
2,193 |
|
Net cash
used in operating activities |
|
|
(41,109 |
) |
|
|
(6,663 |
) |
Cash flows
from investing activities: |
|
|
|
|
|
|
Purchase of property and equipment |
|
|
(622 |
) |
|
|
(43 |
) |
Proceeds from restricted long-term bank deposit |
|
|
— |
|
|
|
414 |
|
Net cash
(used in) provided by investing activities |
|
|
(622 |
) |
|
|
371 |
|
Cash flows
from financing activities: |
|
|
|
|
|
|
Proceeds from reverse capitalization, net of transaction costs |
|
|
249,428 |
|
|
|
— |
|
Proceeds from borrowings |
|
|
6,000 |
|
|
|
— |
|
Repayment of borrowings |
|
|
(6,000 |
) |
|
|
— |
|
Payment of debt issuance costs |
|
|
(50 |
) |
|
|
— |
|
Proceeds from exercise of stock options |
|
|
1,970 |
|
|
|
62 |
|
Net cash
provided by financing activities |
|
|
251,348 |
|
|
|
62 |
|
Change in
cash and cash equivalents |
|
|
209,617 |
|
|
|
(6,230 |
) |
Cash and
cash equivalents at the beginning of the period |
|
|
13,248 |
|
|
|
39,632 |
|
Cash and
cash equivalents at the end of the period |
|
$ |
222,865 |
|
|
$ |
33,402 |
|
Non-GAAP Financial Measures
In addition to our financial results determined
in accordance with GAAP, we believe adjusted EBITDA, a non-GAAP
measure, is useful in evaluating our operating performance. We use
adjusted EBITDA to evaluate our ongoing operations and for internal
planning and forecasting purposes. We believe that this non-GAAP
financial measure, when taken together with the corresponding GAAP
financial measures, provides meaningful supplemental information
regarding our performance by excluding certain items that may not
be indicative of our business, results of operations or outlook. We
believe that the use of adjusted EBITDA is helpful to our investors
as it is a metric used by management in assessing the health of our
business and our operating performance. However, non-GAAP financial
information is presented for supplemental informational purposes
only, has limitations as an analytical tool and should not be
considered in isolation or as a substitute for financial
information presented in accordance with GAAP. In addition, other
companies, including companies in our industry, may calculate
similarly titled non-GAAP measures differently or may use other
measures to evaluate their performance, all of which could reduce
the usefulness of our non-GAAP financial measure as a tool for
comparison. A reconciliation is provided below for this non-GAAP
financial measure to net loss, the most directly comparable
financial measure stated in accordance with GAAP. Investors are
encouraged to review our GAAP financial measure and the
reconciliation of our non-GAAP financial measure to its most
directly comparable GAAP financial measure, and not to rely on any
single financial measure to evaluate our business.
Adjusted EBITDA
Adjusted EBITDA is a key performance measure
that our management uses to assess our operating performance.
Because adjusted EBITDA facilitates internal comparisons of our
historical operating performance on a more consistent basis, we use
this measure for business planning purposes and in evaluating
acquisition opportunities.
We calculate adjusted EBITDA as net loss
adjusted to exclude (i) interest and other expenses (income), net,
(ii) tax benefit and expense, (iii) depreciation and amortization
(iv) stock-based compensation expense and (v) business combination
and other financing expenses.
Talkspace, Inc.
Reconciliation of Non-GAAP Results to GAAP
Results
|
|
Three months ended September
30, |
|
|
Nine months ended September
30, |
|
(in
thousands) |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
Net income (loss) |
|
$ |
1,505 |
|
|
$ |
(2,692 |
) |
|
$ |
(41,674 |
) |
|
$ |
(11,238 |
) |
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
and amortization |
|
|
503 |
|
|
|
19 |
|
|
|
1,458 |
|
|
|
55 |
|
Financial
(income) expense, net (1) |
|
|
(26,743 |
) |
|
|
285 |
|
|
|
(23,700 |
) |
|
|
254 |
|
Taxes on
income |
|
|
11 |
|
|
|
3 |
|
|
|
29 |
|
|
|
12 |
|
Stock-based
compensation |
|
|
3,875 |
|
|
|
336 |
|
|
|
20,584 |
|
|
|
1,069 |
|
Adjusted
EBITDA |
|
$ |
(20,849 |
) |
|
$ |
(2,049 |
) |
|
$ |
(43,303 |
) |
|
$ |
(9,848 |
) |
(1) For the three months ended
September 30, 2021, financial income, net primarily consisted
of $26.9 million in gains resulting from the revaluation of warrant
liabilities. For the nine months ended September 30, 2021,
financial income, net primarily consisted of $28.3 million in gains
resulting from the revaluation of warrant liabilities, partially
offset by $4.2 million in warrant issuance costs in connection with
the close of the Business Combination.
Talkspace, Inc. Active
Members and B2B Eligible Lives
|
Three months ended, |
|
|
Mar. 31,2020 |
|
|
Jun. 30,2020 |
|
|
Sep. 30,2020 |
|
|
Dec. 31,2020 |
|
|
Mar. 31,2021 |
|
|
Jun. 30,2021 |
|
|
Sep. 30,2021 |
|
Active members (in thousands) (1) |
29.4 |
|
|
|
44.0 |
|
|
|
49.9 |
|
|
|
50.0 |
|
|
|
58.7 |
|
|
|
59.4 |
|
|
|
60.3 |
|
B2B eligible
lives (in millions) (1) |
|
9.5 |
|
|
|
33.7 |
|
|
|
39.2 |
|
|
39.4 |
|
|
|
49.5 |
|
|
|
71.9 |
|
|
|
75.3 |
|
(1) Historical amounts have been updated to be
comparable to current period presentation.
Key Business
Metrics
Active Members: We consider members “active” (i)
in the case of our B2C members, commencing on the date such member
initiates contact with a provider on our platform until the term of
their monthly, quarterly or bi-annual subscription plan expires,
unless terminated early, and (ii) in the case of our B2B members,
if such members have engaged on our platform during the preceding
25 days, such as sending a text, video or audio message to, or
participating in a video call with, a provider, completing a
satisfaction or progress report survey or signing up for our
platform. While a growth in active members typically highlights
strong engagement with our members, not all active members are
associated with revenue in that particular period.
B2B Eligible Lives: We consider B2B lives
“eligible” if such persons are eligible to receive treatment on the
Talkspace platform, in the case of its enterprise clients, while
their employer is under an active contract with Talkspace, or, in
the case of health plan clients, at an agreed upon reimbursement
rate through insurance under an employee assistance program or
other network behavioral health paid benefit program. There may be
instances where a person may be covered through multiple solutions,
typically through behavioral health plans and employee assistance
programs. In these instances, the person is counted each time they
are covered in the B2B eligible lives calculation, which may cause
this amount to reflect a higher number of members than we actually
serve.
Talkspace (NASDAQ:TALK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Talkspace (NASDAQ:TALK)
Historical Stock Chart
From Jul 2023 to Jul 2024